Pathologic features of 5 tFL-PMBLsig-pos cases
. | 1 . | 2 . | 3 . | 4 . | 5 . |
---|---|---|---|---|---|
EX00406 . | EX00408 . | EX004010 . | FL1179T2 . | FL1122T2 . | |
Histology | Centroblasts | Centroblasts | Centroblasts | Centroblasts | Centroblasts |
Fine sclerosis | Yes | Yes | Yes | Yes | Yes |
Concurrent FL (histologic grade) | No | Yes (3A) | Yes (1-2) | No | No |
CD10 | + | + | − | − | NA |
BCL6 | + | + | + | + | NA |
IRF4/MUM1 | + | − | − | NA | NA |
CD23 | − | + | + | + | − |
CD30 | − | − | + | − | − |
CD200 | − | + | − | − | − |
CD273/PDL2 | − | − | − | − | − |
MAL | + | + | − | + | + |
Ki-67 | 80% | 50% | NA | 70% | NA |
EBV-ISH (EBER) | − | − | NA | NA | NA |
MYC rearrangement∗ | − | − | − | − | − |
BCL2 rearrangement∗ | + | − | − | − | + |
BCL6 rearrangement∗ | + | − | + | − | − |
COO (Lymph2Cx) | GCB | GCB | UNC | GCB | GCB |
. | 1 . | 2 . | 3 . | 4 . | 5 . |
---|---|---|---|---|---|
EX00406 . | EX00408 . | EX004010 . | FL1179T2 . | FL1122T2 . | |
Histology | Centroblasts | Centroblasts | Centroblasts | Centroblasts | Centroblasts |
Fine sclerosis | Yes | Yes | Yes | Yes | Yes |
Concurrent FL (histologic grade) | No | Yes (3A) | Yes (1-2) | No | No |
CD10 | + | + | − | − | NA |
BCL6 | + | + | + | + | NA |
IRF4/MUM1 | + | − | − | NA | NA |
CD23 | − | + | + | + | − |
CD30 | − | − | + | − | − |
CD200 | − | + | − | − | − |
CD273/PDL2 | − | − | − | − | − |
MAL | + | + | − | + | + |
Ki-67 | 80% | 50% | NA | 70% | NA |
EBV-ISH (EBER) | − | − | NA | NA | NA |
MYC rearrangement∗ | − | − | − | − | − |
BCL2 rearrangement∗ | + | − | − | − | + |
BCL6 rearrangement∗ | + | − | + | − | − |
COO (Lymph2Cx) | GCB | GCB | UNC | GCB | GCB |
The symbol + indicates positive and − indicates negative.
NA, not available; UNC, unclassified.
MYC, BCL2, and BCL6 rearrangements detected by fluorescence in situ hybridization.